Lilly issues "Dear Doctor" letter over risks of Zyprexa in adolescents
This article was originally published in Scrip
Executive Summary
Lilly has issued a "Dear Doctor" letter regarding the use of its atypical antipsychotic Zyprexa (olanzapine) in adolescents to warn of the increased risk of weight gain and hyperlipidemia compared with its use in adults.